How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test can provide context on your genetic predispositions in key GLP-1 signaling pathwaysspecifically variants in GLP1R, GIPR, FTO, and MC4R genes
This product is not a medicine, food or dietary supplement and is not suitable for human consumption
GentleLase was cleared by the FDA in 2014 for safety and efficacy in providing permanent hair reduction on all skin types (Fitzpatrick I- VI) including tanned skin
Molecular Genetics of Attention-Deficit/Hyperactivity Disorder
How PlexusDx Personalization Guides Individual Semaglutide Dosing The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
In humans, changes in intestinal permeability have been linked in the pathogenesis of debilitating inflammatory bowel diseases (IBDs) such as Crohns disease (CD) [1] and in autoimmune diseases such as Celiac disease [2]
